Today on The Daily Dive, we sit down with Jorge Wernli, Commercial and Market Access Director for Creso Pharma (ASX: CPH). Jorge joins us this afternoon to discuss Creso’s CBD operations in Switzerland, the firms product development, and the roles the company plays internationally.
Creso Pharma is an ASX-listed issuer with operations focused on the use of cannabis and hemp across Canada, Europe, Latin America and Australia. In Canada, the company operates its licensed producer, Mernova Medicinal, in Nova Scotia, which focuses on high quality cannabis production. It’s European operations meanwhile are based in Switzerland, where it focuses on its Animal Health, Nutraceutical, and Cosmetics divisions.
Catch the full interview below.
FULL DISCLOSURE: Creso Pharma is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Creso Pharma on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.
Copper Stock Heating Up? – The Daily Dive feat John-Mark Staude of Riverside Resources
Today on the Daily Dive, live direct from the Mexico Mining Conference in Guadalajara, Mexico...